Home » Topics » Regulatory » Patents

Patents
RSS

New reverse transcriptase inhibitors for HIV presented in recent GSK patent

Jan. 21, 2009

Astellas Pharma divulges new prostanoid EP4 receptor agonists for PAD

Jan. 21, 2009

Roche discloses novel tachykinin NK3 receptor antagonists

Jan. 21, 2009

New serotonin reuptake inhibitors and 5-HT1A receptor antagonists discovered at Wyeth

Jan. 21, 2009

Muscarinic M3 receptor ligands and beta2-adrenoceptor agonists imparted by Argenta and AstraZeneca

Jan. 20, 2009

AstraZeneca imparts novel metabotropic glutamate receptor oxadiazole ligands

Jan. 20, 2009

New ERK2 inhibitors with oncolytic activity reported in recent Schering-Plough patent

Jan. 20, 2009

Novel Jak kinase inhibitors in early development at Novartis

Jan. 20, 2009

Boehringer Ingelheim divulges novel protein kinase inhibitors for use in treating cancer

Jan. 20, 2009

Novel protein kinase inhibitors with anticancer properties disclosed by Takeda

Jan. 19, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...